Patents by Inventor H.P. Schultheiss

H.P. Schultheiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • B-lymphocyte targeting agents for use in a method for the treatment of a disease
    Patent number: 10144777
    Abstract: The present invention is related to a B-lymphocyte targeting agent for use in a method for the treatment or diagnosis of cardiac insufficiency. Furthermore, it is related to a composition comprising such B-lymphocyte targeting agent and methods for determining whether a patient suffering from cardiac insufficiency is amenable to the use of the B-lymphocyte targeting agent for its treatment.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: December 4, 2018
    Assignee: Charité—Universitätsmedizin Berlin
    Inventors: Carsten Tschöpe, H. P. Schultheiss, Felicitas Escher, Hans-Dieter Volk, Petra Reinke
  • B-Lymphocyte Targeting Agents for Use in a Method for the Treatment of a Disease
    Publication number: 20120100069
    Abstract: The present invention is related to a B-lymphocyte targeting agent for use in a method for the treatment or diagnosis of cardiac insufficiency. Furthermore, it is related to a composition comprising such B-lymphocyte targeting agent and methods for determining whether a patient suffering from cardiac insufficiency is amenable to the use of the B-lymphocyte targeting agent for its treatment.
    Type: Application
    Filed: April 16, 2010
    Publication date: April 26, 2012
    Inventors: Carsten Tschöpe, H.P. Schultheiss, Felicitas Escher, Hans-Dieter Volk, Petra Reinke